Valuation Caplin Point Laboratories Limited

Stocks

Delayed Bombay S.E. Other stock markets 03:07:34 2026-07-24 am EDT			5-day change	1st Jan Change
2,514.40 ^INR	+1.10%		-3.81%	+36.56%

May. 14	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
May. 14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	189,052	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	24.2%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	189,052	189,052	189,052
Change	-	68.55%	-12.11%	120.88%	52.16%	24.2%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	26.5x	23.3x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.3x	3.9x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.7x	1.7x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.6x	6.74x
EV / Revenue	0x	0x	0x	0x	0x	8.88x	7.6x	6.74x
EV / EBITDA	0x	0x	0x	0x	0x	25.5x	22x	19.3x
EV / EBIT	0x	0x	0x	-	0x	24.3x	20.3x	17.6x
EV / FCF	0x	0x	0x	0x	0x	49.8x	34.4x	34.9x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.91%	2.86%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.16%	0.16%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,487.15	2,487.15	2,487.15
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	5/6/21	5/12/22	5/27/23	5/16/24	5/15/25	5/14/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	30.67x	-	-	-	1.95B
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.81x	6.76x	23.37x	0.81%	48.41B
OTSUKA HOLDINGS CO., LTD.	17.97x	2.03x	9.59x	1.33%	34.99B
CIPLA LIMITED	27.22x	3.3x	17.11x	0.84%	11.62B
ZYDUS LIFESCIENCES LIMITED	26.4x	3.9x	15.87x	0.6%	11.47B
KRKA, D. D.	19.11x	3.34x	11.98x	3.48%	8.99B
ONO PHARMACEUTICAL CO., LTD.	15.88x	2.04x	6.86x	3.27%	6.88B
GEDEON RICHTER	8.14x	1.9x	4.98x	5.33%	6.62B
GLENMARK PHARMACEUTICALS LIMITED	33.47x	3.81x	16.2x	0.24%	6.43B
Average	23.85x	3.39x	13.25x	1.99%	15.26B
Weighted average by Cap.	26.15x	4.16x	15.80x	1.43%